vs
Side-by-side financial comparison of CIMPRESS plc (CMPR) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
CIMPRESS plc is the larger business by last-quarter revenue ($1.0B vs $617.8M, roughly 1.7× Hims & Hers Health, Inc.). CIMPRESS plc runs the higher net margin — 4.7% vs 3.3%, a 1.4% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 11.0%). CIMPRESS plc produced more free cash flow last quarter ($139.5M vs $-2.5M).
Cimpress plc is an American Irish-domiciled multinational technology company that invests in and operates a wide variety of businesses that use mass customization to configure and produce small quantities of individually customized goods. Those products are sold to small businesses, graphic designers and consumers through a number of customer-facing brands that Cimpress operates.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
CMPR vs HIMS — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $617.8M |
| Net Profit | $49.3M | $20.6M |
| Gross Margin | 46.8% | 71.9% |
| Operating Margin | 8.5% | 1.5% |
| Net Margin | 4.7% | 3.3% |
| Revenue YoY | 11.0% | 28.4% |
| Net Profit YoY | -19.2% | -20.8% |
| EPS (diluted) | $1.95 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $617.8M | ||
| Q3 25 | $863.3M | $599.0M | ||
| Q2 25 | — | $544.8M | ||
| Q1 25 | — | $586.0M | ||
| Q4 24 | — | $481.1M | ||
| Q3 24 | — | $401.6M | ||
| Q2 24 | — | $315.6M | ||
| Q1 24 | — | $278.2M |
| Q4 25 | $49.3M | $20.6M | ||
| Q3 25 | $7.6M | $15.8M | ||
| Q2 25 | — | $42.5M | ||
| Q1 25 | — | $49.5M | ||
| Q4 24 | — | $26.0M | ||
| Q3 24 | — | $75.6M | ||
| Q2 24 | — | $13.3M | ||
| Q1 24 | — | $11.1M |
| Q4 25 | 46.8% | 71.9% | ||
| Q3 25 | 46.7% | 73.8% | ||
| Q2 25 | — | 76.4% | ||
| Q1 25 | — | 73.5% | ||
| Q4 24 | — | 76.8% | ||
| Q3 24 | — | 79.2% | ||
| Q2 24 | — | 81.3% | ||
| Q1 24 | — | 82.4% |
| Q4 25 | 8.5% | 1.5% | ||
| Q3 25 | 5.7% | 2.0% | ||
| Q2 25 | — | 4.9% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 5.6% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 3.6% |
| Q4 25 | 4.7% | 3.3% | ||
| Q3 25 | 0.9% | 2.6% | ||
| Q2 25 | — | 7.8% | ||
| Q1 25 | — | 8.4% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | — | 18.8% | ||
| Q2 24 | — | 4.2% | ||
| Q1 24 | — | 4.0% |
| Q4 25 | $1.95 | $0.08 | ||
| Q3 25 | $0.30 | $0.06 | ||
| Q2 25 | — | $0.17 | ||
| Q1 25 | — | $0.20 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.32 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $258.0M | $228.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-530.7M | $540.9M |
| Total Assets | $2.1B | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $258.0M | $228.6M | ||
| Q3 25 | $200.5M | $345.8M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $273.7M | ||
| Q4 24 | — | $220.6M | ||
| Q3 24 | — | $165.5M | ||
| Q2 24 | — | $129.3M | ||
| Q1 24 | — | $105.2M |
| Q4 25 | $-530.7M | $540.9M | ||
| Q3 25 | $-571.3M | $581.0M | ||
| Q2 25 | — | $562.7M | ||
| Q1 25 | — | $549.3M | ||
| Q4 24 | — | $476.7M | ||
| Q3 24 | — | $440.1M | ||
| Q2 24 | — | $362.0M | ||
| Q1 24 | — | $344.5M |
| Q4 25 | $2.1B | $2.2B | ||
| Q3 25 | $2.0B | $2.2B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $891.7M | ||
| Q4 24 | — | $707.5M | ||
| Q3 24 | — | $602.3M | ||
| Q2 24 | — | $480.5M | ||
| Q1 24 | — | $448.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $164.7M | $61.3M |
| Free Cash FlowOCF − Capex | $139.5M | $-2.5M |
| FCF MarginFCF / Revenue | 13.4% | -0.4% |
| Capex IntensityCapex / Revenue | 2.4% | 10.3% |
| Cash ConversionOCF / Net Profit | 3.34× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | — | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.7M | $61.3M | ||
| Q3 25 | $25.1M | $148.7M | ||
| Q2 25 | — | $-19.1M | ||
| Q1 25 | — | $109.1M | ||
| Q4 24 | — | $86.4M | ||
| Q3 24 | — | $85.3M | ||
| Q2 24 | — | $53.6M | ||
| Q1 24 | — | $25.8M |
| Q4 25 | $139.5M | $-2.5M | ||
| Q3 25 | $-1.3M | $79.3M | ||
| Q2 25 | — | $-69.5M | ||
| Q1 25 | — | $50.1M | ||
| Q4 24 | — | $59.5M | ||
| Q3 24 | — | $79.4M | ||
| Q2 24 | — | $47.6M | ||
| Q1 24 | — | $11.8M |
| Q4 25 | 13.4% | -0.4% | ||
| Q3 25 | -0.1% | 13.2% | ||
| Q2 25 | — | -12.8% | ||
| Q1 25 | — | 8.5% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 19.8% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | — | 4.3% |
| Q4 25 | 2.4% | 10.3% | ||
| Q3 25 | 3.1% | 11.6% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | 10.1% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 5.0% |
| Q4 25 | 3.34× | 2.98× | ||
| Q3 25 | 3.28× | 9.43× | ||
| Q2 25 | — | -0.45× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 3.32× | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 4.03× | ||
| Q1 24 | — | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMPR
| Vista | $532.8M | 51% |
| Print Brothers | $219.9M | 21% |
| National Pen | $150.9M | 14% |
| The Print Group | $115.2M | 11% |
| All Other Businesses | $67.2M | 6% |
HIMS
Segment breakdown not available.
